BlueCrest Capital Management Ltd

Position in RNA — Atrium Therapeutics, Inc.

CIK 1610880 ST HELIER, Y9

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,345,000

New position

Shares Held

100,000

first reported quarter

Ownership

0.585%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#44

of 153 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BlueCrest Capital Management Ltd holds $3,702,055 across 3 Biotechnology names. RNA ranks #2 (36.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	85,157	$2,297,535
2	RNA	Atrium Therapeutics, Inc. This page	100,000	$1,345,000
3	BHVN	Biohaven Ltd.	4,000	$59,520

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,345,000	100,000	—	Shares	Other	2026-08-14
No filing history on record for this holder in this stock.